Probiotec Ltd
XBER:PG3

Watchlist Manager
Probiotec Ltd Logo
Probiotec Ltd
XBER:PG3
Watchlist
Price: 1.79 EUR -1.65% Market Closed
Market Cap: 145.6m EUR

Wall Street
Price Targets

PG3 Price Targets Summary
Probiotec Ltd

There are no price targets for PG3.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Probiotec Ltd Competitors:
Price Targets
600521
Zhejiang Huahai Pharmaceutical Co Ltd
24% Upside
ERIS
Eris Lifesciences Ltd
20% Upside
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
30% Downside
300363
Porton Pharma Solutions Ltd
30% Upside
000423
Dong-E-E-Jiao Co Ltd
57% Upside
216080
Jetema Co Ltd
51% Upside
NEU
Neuren Pharmaceuticals Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
Probiotec Ltd

For the last 8 years the compound annual growth rate for Probiotec Ltd's revenue is 16%. The projected CAGR for the next 3 years is 8%.

16%
Past Growth
8%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Probiotec Ltd

For the last 8 years the compound annual growth rate for Probiotec Ltd's operating income is 53%. The projected CAGR for the next 3 years is 16%.

53%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Net Income
Forecast

Net Income Estimate
Probiotec Ltd

The compound annual growth rate of Probiotec Ltd's net income for the next 3 years is 20%.

N/A
Past Growth
20%
Estimated Growth
Estimates Accuracy
-30%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PG3's stock price target?
Not Available

PG3 doesn't have any price targets made by Wall Street professionals.

What is Probiotec Ltd's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Probiotec Ltd's revenue is 16%. The projected CAGR for the next 3 years is 8%.

What is Probiotec Ltd's Operating Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Probiotec Ltd's operating income is 53%. The projected CAGR for the next 3 years is 16%.

What is Probiotec Ltd's Net Income forecast?
Projected CAGR
20%

The compound annual growth rate of Probiotec Ltd's net income for the next 3 years is 20%.

Back to Top